With your own knowledge and the help of the following document:

Document 1 (Title: Pathophysiology of Progressive Kidney Disease): Chronic renal failure represents the final common pathway of numerous kidney diseases characterized by irreversible nephron loss and progressive deterioration of renal function. Pathological examination demonstrates ongoing nephron destruction through various mechanisms including glomerulosclerosis, tubulointerstitial fibrosis, and vascular alterations, with compensatory hyperfiltration in remaining nephrons ultimately accelerating their deterioration. Laboratory assessment reveals characteristic patterns including decreased glomerular filtration rate most accurately reflected through reduced creatinine clearance measurements, providing quantitative assessment of disease progression and severity. Electrolyte derangements develop in predictable patterns, with calcium metabolism particularly affected through multiple mechanisms. Hypocalcemia commonly develops through reduced 1,25-dihydroxyvitamin D synthesis, phosphate retention, skeletal resistance to parathyroid hormone, and calcium-phosphate deposition in soft tissues. Hematological complications prominently feature normocytic anemia resulting from decreased erythropoietin production, uremic inhibitors of erythropoiesis, shortened red cell survival, and occasional blood loss from uremic platelet dysfunction. Acid-base regulation becomes progressively impaired as nephron mass declines, with metabolic acidosis developing through reduced hydrogen ion excretion and bicarbonate regeneration. This acidosis further complicates protein metabolism, bone disease, and muscle catabolism. Potassium homeostasis typically remains relatively preserved until advanced disease stages, with hyperkalemia rather than hypokalemia characterizing end-stage renal failure as adaptive increases in colonic potassium secretion eventually prove insufficient to maintain normal serum levels. This constellation of pathophysiological changes creates the characteristic clinical and laboratory presentation of advanced kidney disease, guiding both supportive management approaches and decisions regarding renal replacement therapy initiation.
Document 2 (Title: Clinical Manifestations of Ethylene Glycol Exposure): Ethylene glycol intoxication presents a distinctive multi-system toxidrome requiring prompt recognition and intervention due to its potentially lethal consequences. Following ingestion, the parent compound undergoes hepatic metabolism generating multiple toxic metabolites with widespread organ impacts. Kidney injury represents a hallmark manifestation, with calcium oxalate crystalluria progressing to acute tubular necrosis and potential renal failure within 24-72 hours post-ingestion. Characteristic neurological involvement occurs in a biphasic pattern, with initial CNS depression followed by delayed cerebral edema, seizures, and potentially irreversible neurological damage mediated through metabolite neurotoxicity. Profound metabolic derangements typically develop as the intoxication progresses, including a severe high-anion-gap metabolic acidosis resulting from glycolic and oxalic acid accumulation. Concurrent electrolyte abnormalities frequently complicate management, particularly hypocalcemia secondary to calcium oxalate formation. Cardiopulmonary manifestations emerge in moderate to severe poisonings, including myocardial depression, conduction disturbances, and in severe cases, circulatory collapse requiring vasopressor support. Multiple case series document QT prolongation and tachyarrhythmias in significant exposures, sometimes necessitating advanced cardiac life support interventions. Comprehensive toxicology references describe additional rare manifestations in severe cases, though notably excluding ototoxicity or permanent hearing alterations, which remain absent from major case registries despite extensive documentation of other system effects. These collective manifestations create a recognizable pattern distinguishing ethylene glycol poisoning from other toxic alcohol ingestions, guiding appropriate diagnostic and therapeutic interventions including fomepizole administration, potential hemodialysis, and supportive care.
Document 3 (Title: Viral Hepatitis: Epidemiology and Clinical Significance): Hepatitis B virus (HBV) represents a significant global health challenge with distinctive virological characteristics and diverse clinical manifestations. Virological classification identifies this pathogen as a member of the Hepadnaviridae family with a partially double-stranded DNA genome utilizing reverse transcriptase during replication, distinguishing it from RNA viruses causing related hepatic diseases. The virus demonstrates remarkable environmental stability, contributing to its documented role in nosocomial transmission through inadequately sterilized medical equipment, particularly in hemodialysis settings and during certain surgical procedures. Clinical course variability represents a hallmark feature, with acute infection potentially progressing to chronic hepatitis in 5-10% of immunocompetent adults and significantly higher percentages in perinatally infected individuals. This chronicity creates substantial long-term complications including cirrhosis and hepatocellular carcinoma through complex inflammatory and oncogenic mechanisms. Particularly concerning manifestations include fulminant hepatic failure occurring in approximately 0.5-1% of acute infections, characterized by massive hepatocellular necrosis, coagulopathy, and encephalopathy with mortality rates exceeding 80% without liver transplantation. Preventive approaches center on recombinant vaccine formulations containing HBsAg produced in yeast expression systems, representing an inactivated subunit vaccine rather than live attenuated preparations. This vaccination strategy has demonstrated remarkable success in reducing infection rates worldwide, though implementation challenges remain in certain regions. Clinical management continues to evolve with development of nucleoside/nucleotide analogs and immunomodulatory approaches for chronic infection, though therapeutic challenges persist particularly regarding viral clearance and prevention of long-term complications.

Answer the following list question.
Question: In untreated chronic renal failure, the following is/are observed:
Options:
1. Progressive destruction of nephrons
2. Hypocalcemia
3. Anemia
4. Hypokalemia
5. Decreased renal clearance of creatinine

Respond strictly in valid JSON format as shown below:
{"answer": ["1", "3"]} ‚Üê if options 1 and 3 are correct
Only output the JSON object. Do not include explanations, labels, markdown, or any other text.